{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:56:55Z","timestamp":1779879415450,"version":"3.53.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              The characteristics of patients undergoing atrial fibrillation (\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ) ablation and subsequent outcomes in community practice are not well described.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Using the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (\n              <jats:styled-content style=\"fixed-case\">ORBIT<\/jats:styled-content>\n              \u2010\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ), we investigated the prevalence and impact of catheter ablation of\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              . Among 9935 patients enrolled, 5.3% had previous\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ablation. Patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ablation were significantly younger, more frequently male, and had less anemia, chronic obstructive pulmonary disease, and previous myocardial infarction (P&lt;0.05 for all analyses) than those without previous catheter ablation of\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              . Ablated patients were more likely to have a family history of\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              , obstructive sleep apnea, paroxysmal\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              , and moderate\u2010to\u2010severe symptoms (P&lt;0.0001 for all analyses). Patients with previous ablation were more often in sinus rhythm on entry into the registry (52% vs. 32%; P&lt;0.0001). Despite previous ablation, 46% in the ablation group were still on antiarrhythmic therapy. Oral anticoagulation was prescribed in 75% of those with previous ablation versus 76% in those without previous ablation (P=0.5). The adjusted risk of death (hazard ratio [\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              ], 0.78; 95% confidence interval [\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              ], 0.52 to 1.18; P=0.2) and cardiovascular (\n              <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n              ) hospitalization (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              , 1.06; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 0.90 to 1.26; P=0.5) were similar in both groups. Patients with incident\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              ablation had higher risk of subsequent\n              <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n              hospitalization than matched patients without incident ablation (\n              <jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>\n              , 1.67; 95%\n              <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n              , 1.24 to 2.26; P=0.0008).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              In U.S. clinical practice, a minority of patients with\n              <jats:styled-content style=\"fixed-case\">AF<\/jats:styled-content>\n              are managed with catheter ablation. Subsequent to ablation, there were no significant differences in oral anticoagulation use or outcomes, including stroke\/non\u2013central nervous system embolism\/transient ischemic attack or death.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Clinical Trial Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              <jats:styled-content style=\"fixed-case\">URL<\/jats:styled-content>\n              :\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">http:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              . Unique identifier:\n              <jats:styled-content style=\"fixed-case\">NCT<\/jats:styled-content>\n              01165710.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.115.001901","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T01:55:31Z","timestamp":1432259731000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["Catheter Ablation of Atrial Fibrillation in U.S. Community Practice\u2014Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT\u2010AF)"],"prefix":"10.1161","volume":"4","author":[{"given":"Fredrik","family":"Holmqvist","sequence":"first","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaJuanicia","family":"Simon","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jae","family":"Hong","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[{"name":"Lankenau Hospital and Medical Research Center Philadelphia PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Reiffel","sequence":"additional","affiliation":[{"name":"Columbia University New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[{"name":"Penn State Milton S. Hershey Medical Center Hershey PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Chang","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceuticals, Inc Raritan NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine Rochester MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ORBIT\u2010AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.109.859116"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000041"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.109.856633"},{"key":"e_1_3_1_5_2","first-page":"CD007101","article-title":"Catheter ablation for paroxysmal and persistent atrial fibrillation","volume":"4","author":"Chen HS","year":"2012","unstructured":"Chen HS, Wen JM, Wu SN, Liu JP. Catheter ablation for paroxysmal and persistent atrial fibrillation. Cochrane Database Syst Rev. 2012;4:CD007101.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.10.012"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.12.019"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.068"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.07.001"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi505"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2011.02043.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.11.026"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3283413978"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000157738.12783.71"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.04.024"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1370\/afm.940"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2012.03482.x"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.061"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2011.08.021"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.05.022"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12192"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300720"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.11.039"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121736.16643.11"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00577-1"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2011.02035.x"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus336"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.115.001901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:35:47Z","timestamp":1715596547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.115.001901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1161\/JAHA.115.001901"],"URL":"https:\/\/doi.org\/10.1161\/jaha.115.001901","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"2015-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e001901"}}